GDS: The UK’s Biggest Ever Cannabis Survey

 

Why is the Global Drug Survey (GDS) running a UK cannabis survey?

 

GDS runs one very big drug survey each year, the annual Global Drug Survey. It's the largest drug survey in the world. Our next survey, GDS2020, launches in November 2019. It will be translated into 18 languages, have partners in 30 countries and include a big focus on psychedelics, medical cannabis, CBD, MDMA dosing and nightlife.

We don’t usually interrupt the flow at GDS with another survey. But such is the speed of change and deluge of investor funding and interest in the UK cannabis market (both legal and medical), that GDS thought it was really important to get some sense of what is going on now - in the UK today - to inform future policy, clinical guidelines and ensure the voice of the everyday consumer is heard. The narrative to date has not always offered this.

So, we have teamed up with the UK Cannabis Social Clubs network to run what we expect will be the biggest survey of cannabis use ever conducted in the UK. It will take most people 10-20 minutes. It's hosted at www.globaldrugsurvey.com/cannabis.

It's anonymous, confidential and hosted on an encrypted survey platform and website. We collect no IP addresses and it's approved by the research ethics committee at University College London. 

Your experience is important! Please share it with us. Whether you use cannabis and/or CBD in the UK for pleasure, pain management, or just to pass the time, we want to hear from you.

 

What do we hope to learn and share with you, once we have crunched the numbers?

 

  • How the types of cannabis and the way we use them are changing in the UK
  • How people are using CBD and what do they find it useful for
  • People’s experience of being part of a Cannabis Social Club in the UK
  • How people are currently using cannabis for medical/therapeutic purposes, where they sourcing it from, what they pay, what they use it to treat, how they use it, what benefits they get, the impact on other treatments they may have tried, problems they have experienced and whether or not they have asked a GP or specialist to prescribe cannabis since the law changes in the UK.

 

To take part the survey, visit: www.globaldrugsurvey.com/cannabis

 

*The UK Cannabis Survey is lead by: Professor Adam R Winstock, Consultant Psychiatrist and Founder of the Global Drug Survey; & Greg de Hoedt, UK Cannabis Social Clubs